Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Quick Search
My eDoc
Session History
Support Wiki
Direct access to
document ID:

          Institute: MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut)     Collection: Yearbook 2016     Display Documents

ID: 723918.0, MPI für Herz- und Lungenforschung (W. G. Kerckhoff Institut) / Yearbook 2016
Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension
Authors:Szekeres, M.; Nadasy, G. L.; Turu, G.; Soltesz-Katona, E.; Benyo, Z.; Offermanns, S.; Ruisanchez, E.; Szabo, E.; Takats, Z.; Batkai, S.; Toth, Z. E.; Hunyady, L.
Date of Publication (YYYY-MM-DD):2015-03-05
Title of Journal:Mol Cell Endocrinol
Start Page:46
End Page:56
Audience:Not Specified
Abstract / Description:Activation of G protein-coupled receptors (GPCRs) can induce vasoconstriction via calcium signal-mediated and Rho-dependent pathways. Earlier reports have shown that diacylglycerol produced during calcium signal generation can be converted to an endocannabinoid, 2-arachidonoylglycerol (2-AG). Our aim was to provide evidence that GPCR signaling-induced 2-AG production and activation of vascular type1 cannabinoid receptors (CB1R) is capable of reducing agonist-induced vasoconstriction and hypertension. Rat and mouse aortic rings were examined by myography. Vascular expression of CB1R was demonstrated with immunohistochemistry. Rat aortic vascular smooth muscle cells (VSMCs) were cultured for calcium measurements and 2-AG-determination. Inhibition or genetic loss of CB1Rs enhanced vasoconstriction induced by angiotensin II (AngII) or phenylephrine (Phe), but not by prostaglandin(PG)F2alpha. AngII-induced vasoconstriction was augmented by inhibition of diacylglycerol lipase (tetrahydrolipstatin) and was attenuated by inhibition of monoacylglycerol lipase (JZL184) suggesting a functionally relevant role for endogenously produced 2-AG. In Galphaq/11-deficient mice vasoconstriction was absent to AngII or Phe, which activate Gq/11-coupled receptors, but was maintained in response to PGF2alpha. In VSMCs, AngII-stimulated 2-AG-formation was inhibited by tetrahydrolipstatin and potentiated by JZL184. CB1R inhibition increased the sustained phase of AngII-induced calcium signal. Pharmacological or genetic loss of CB1R function augmented AngII-induced blood pressure rise in mice. These data demonstrate that vasoconstrictor effect of GPCR agonists is attenuated via Gq/11-mediated vascular endocannabinoid formation. Agonist-induced endocannabinoid-mediated CB1R activation is a significant physiological modulator of vascular tone. Thus, the selective modulation of GPCR signaling-induced endocannabinoid release has a therapeutic potential in case of increased vascular tone and hypertension.
Free Keywords:Angiotensin II/pharmacology; Animals; Aorta/*drug effects; Arachidonic Acids/*pharmacology; Benzodioxoles/pharmacology; Calcium/metabolism; Calcium Signaling; Dinoprost/pharmacology; Endocannabinoids/*pharmacology; GTP-Binding Protein alpha Subunits, Gq-G11/deficiency/*genetics; Gene Expression Regulation; Glycerides/*pharmacology; Hypertension/drug therapy/genetics/*metabolism/physiopathology; Lactones/pharmacology; Lipoprotein Lipase/antagonists & inhibitors/genetics/metabolism; Male; Mice; Mice, Knockout; Monoacylglycerol Lipases/antagonists & inhibitors/genetics/metabolism; Muscle, Smooth, Vascular/cytology/drug effects/metabolism; Myocytes, Smooth Muscle/cytology/drug effects/metabolism; Phenylephrine/pharmacology; Piperidines/pharmacology; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1/antagonists & inhibitors/genetics/*metabolism; Tissue Culture Techniques; Vasoconstriction/*drug effects; Angiotensin II; Blood pressure; Endocannabinoid; G protein-coupled receptor; Vasoconstriction
External Publication Status:published
Document Type:Article
Communicated by:n.n.
Affiliations:MPI für physiologische und klinische Forschung
External Affiliations:Institute of Human Physiology and Clinical Experimental Research, Semmelweis University, Budapest, Hungary. Department of Pharmacology, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany. 1st Department of Pediatrics, Semmelweis University, Budapest, Hungary. Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany. Department of Anatomy, Histology and Embryology, Semmelweis University, Budapest, Hungary. Department of Physiology, Semmelweis University, Budapest, Hungary; MTA-SE Laboratory of Molecular Physiology, Budapest, Hungary. Electronic address: hunyady@eok.sote.hu.
Identifiers:ISSN:1872-8057 (Electronic) 0303-7207 (Linking) %R 10.1016/j.mce.2015.01.012
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.